5 results
To characterize the exposure-response relationship of MVT-602 effects on luteinizing hormone (LH) concentrations after subcutaneous administration of single 0.1 to 3 µg doses of MVT-602 or placebo in healthy premenopausal women undergoing COS to…
The main objective of this study is investigating whether augmented reality can provoke symptoms in patients with contamination-based OCD by evaluating how this AR HMD symptom provocation compares to a traditional symptom provocation.
Lu AF28996 is an orally administered investigational compound of a potent, long-acting dopamine agonist, Lu AA40326, currently under development by H. Lundbeck A/S for the treatment of Parkinson*s disease (PD). Primary Objective:to investigate the…
The main objective of this study is to investigate whether body ownership directly influnces the perception of pain in individuals with BIID. The secondary outcome examines whether or not AR is also an effective tool for ameliorating physical and…
The main objective of this study is to investigate whether perspective (i.e. first person vs. third person) directly influences the interplay between body ownership and pain perception.